Venrock Healthcare Capital Partners III L.P. 13D and 13G filings for Cabaletta Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Sale | 2024-09-30 | 13G | Cabaletta Bio, Inc. CABA | Venrock Healthcare Capital Partners III L.P. | 1,590,696 3.300% | -973,256 (-37.96%) | Filing |
| 2024-02-14 8:53 pm Purchase | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | Venrock Healthcare Capital Partners III L.P. | 2,563,952 6.400% | 668,667 (+35.28%) | Filing |
| 2022-12-23 4:15 pm Purchase | 2022-12-13 | 13G | Cabaletta Bio, Inc. CABA | Venrock Healthcare Capital Partners III L.P. | 1,895,285 6.500% | 1,895,285 (New Position) | Filing |